Bandage containing foetal fibroblasts and keratinocytes
US11351201B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 12, 2013 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jun 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes a composition comprising a mixture of human foetal keratinocyte cells and human foetal fibroblast cells, the ratio between said keratinocyte and fibroblast cells ranging from 0.75 to 2.5, preferably being 1:1 or 7:3. This composition is advantageously included in a bandage, said bandage preferably being sterile and packaged in a container impermeable to microorganisms. The present invention finally concerns the use of this composition as a drug, in particular for treating a skin defect (wound, burn or ulcer).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.